Since NRF2/KEAP1 axis is a redox regulator and a target of brusatol, we first evaluated the expression levels of NFE2L2 in ALL cell lines, which encodes for the NRF2 protein and KEAP1, the natural inhibitor of NRF2 (Figure 2). This evidence concerns the gene NFE2L2 and acute lymphoblastic leukemia.